Nyt fra tidsskrifterne
51 ud af 51 tidsskrifter valgt, søgeord (malaria) valgt, emner højest 180 dage gamle, sorteret efter nyeste først.
205 emner vises.
-
Economic evaluation of anti-malarial drug policies across presidential regimes in Nigeria: A comparative analysis from 1999 to presentPLoS One Infectious DiseasesTilføjet 12. marts 2026
-
[Articles] Artesunate–pyronaridine–atovaquone–proguanil and artesunate–fosmidomycin–clindamycin compared with standard artesunate–pyronaridine for the treatment of uncomplicated malaria (MultiMal): a randomised, controlled, clinical, phase 2 trial in Gabon and GhanaLancet MicrobeTilføjet 11. marts 2026
-
[Articles] Parasite clearance in patients with Plasmodium vivax monoinfection treated with artesunate in Cambodia: an observational secondary analysis of trial dataLancet MicrobeTilføjet 11. marts 2026
-
In Vivo Antimalarial Activity and Toxicological Profile of LAFIS10, a Piperazine Derivative From Ursolic AcidTropical Medicine & International HealthTilføjet 7. marts 2026
-
Exploring the importance and preference of sugar feeding behaviour of malaria vectors in sugar plantations of southern MalawiPLoS One Infectious DiseasesTilføjet 7. marts 2026
-
[Editorial] Funding relief, but conditions temper optimismLancet HIVTilføjet 5. marts 2026
-
Diagnostic Accuracy of Point‐of‐Care Devices for Glucose‐6‐Phosphate Dehydrogenase Deficiency Detection Among Malaria Patients: A Systematic Review and Meta‐AnalysisTropical Medicine & International HealthTilføjet 4. marts 2026
-
Climate shocks, not just warming, threaten malaria control efforts in AfricaNatureTilføjet 4. marts 2026
-
Arboviral antibody biomarkers and fetomaternal outcomes in pregnant women with and without HIV across Nigeria: A multi-regional cross-sectional studyInternational Journal of Infectious DiseasesTilføjet 3. marts 2026
-
Designing novel bisquinoline antimalarials from historical 4-aminoquinolines to combat drug-resistant malariaAntimicrobial Agents And ChemotherapyTilføjet 3. marts 2026
-
A protein-based self-assembled nanoparticle provides an improved malarial vaccineTrends in ParasitologyTilføjet 28. februar 2026
-
Asymptomatic malaria: a hidden reservoir for the transmission and circulation of artemisinin partial-resistant Plasmodium falciparum in TanzaniaEmerg Microbes InfectTilføjet 27. februar 2026
-
Shifting metabolism alters rRNA expression in malaria parasitesTrends in ParasitologyTilføjet 24. februar 2026
-
Immune interactions of entomopathogens with mosquito and tick vectorsTrends in ParasitologyTilføjet 24. februar 2026
-
Irène landau: a life devoted to parasitologyTrends in ParasitologyTilføjet 24. februar 2026
-
Placental malaria in nineteenth-century ScotlandInfection and ImmunityTilføjet 24. februar 2026
-
A Fe-incorporated bioreactor platform exhibiting antimalarial activity and enhanced response to artemisininAntimicrobial Agents And ChemotherapyTilføjet 21. februar 2026
-
Molecular evidence of co-circulation of different dengue virus serotypes associated with malaria co-infection among febrile children in Libreville, GabonInternational Journal of Infectious DiseasesTilføjet 19. februar 2026
-
Reduced cyclin D3 expression in erythroid cells protects against malariaNatureTilføjet 19. februar 2026
-
Malaria is hindered by repression of a cell-cycle proteinNatureTilføjet 19. februar 2026
-
Transmembrane proteins mediate basal complex assembly and individual daughter cell formation in malaria parasitesScience AdvancesTilføjet 19. februar 2026
-
Changing genetic profiles of Plasmodium falciparum piperaquine resistance in Southeast Asia over 25 yearsAntimicrobial Agents And ChemotherapyTilføjet 18. februar 2026
-
Climate change could hinder malaria eradication effortsNature MedicineTilføjet 14. februar 2026
-
[Articles] Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysisLancet MicrobeTilføjet 13. februar 2026
-
[Articles] Effectiveness and safety of 7-day high-dose primaquine and single-dose tafenoquine versus 14-day low-dose primaquine in patients with Plasmodium vivax malaria (EFFORT): a multicentre, open-label, randomised, controlled, superiority trialLancet Infectious DiseasesTilføjet 12. februar 2026
-
Postpartum cytokine shifts and IL-10–mediated immune suppression in malaria-infected primigravid womenPLoS One Infectious DiseasesTilføjet 10. februar 2026
-
Multicentric longitudinal study on malaria burden, vector bionomics and health system assessment in diverse eco-epidemiological settings in the context of malaria elimination in India: study protocolBMJ OpenTilføjet 10. februar 2026
-
Detection of Novel Pegivirus C Genome in an Unexplained Febrile Outbreak, Gombe State, Nigeria, 2024 by Enhanced mNGS ApproachInternational Journal of Infectious DiseasesTilføjet 9. februar 2026
-
Malaria service readiness and associated factors among health facilities that provide antenatal care services in Ethiopia: a cross-sectional study using generalised estimating equation analysisBMJ OpenTilføjet 5. februar 2026
-
Field evaluation of drone and AI assisted larval source management in GhanaPLoS One Infectious DiseasesTilføjet 5. februar 2026
-
[Media Watch] Leishmaniasis: a story of two continentsLancet Infectious DiseasesTilføjet 5. februar 2026
-
Projected impacts of climate change on malaria in AfricaNatureTilføjet 30. januar 2026
-
Sudan’s complex genetic admixture history drives adaptation to malaria in Sudanese CoptsProceedings of the National Academy of SciencesTilføjet 21. januar 2026
-
The endemic dilemma: why whole sporozoite malaria vaccine efficacy falls in the fieldTrends in ParasitologyTilføjet 21. januar 2026
-
[Editorial] We have the means to beat malaria, do we have the will?Lancet MicrobeTilføjet 20. januar 2026
-
First-in-human safety and pharmacokinetics of MK-7602, the antimalarial inhibitor of plasmepsins IX/X, in single- and multiple-ascending-dose studiesAntimicrobial Agents And ChemotherapyTilføjet 15. januar 2026
-
Computational screening of natural inhibitors against Plasmodium falciparum kinases: Toward novel antimalarial therapiesPLoS One Infectious DiseasesTilføjet 14. januar 2026
-
Genetic Determinants for Vivax Malaria Susceptibility in Chiplun (Ratnagiri), Maharashtra, India: A Case–Control StudyTropical Medicine & International HealthTilføjet 13. januar 2026
-
MicroRNAs profiling in malaria and arbovirus coinfection: A systematic review protocolPLoS One Infectious DiseasesTilføjet 9. januar 2026
-
MAP-X unveils the shapeshifting interactome of Plasmodium falciparumTrends in ParasitologyTilføjet 9. januar 2026
-
[Articles] The effectiveness of long-lasting spatial repellent emanators against malaria in humanitarian crisis settings in northern Nigeria: a two-arm pragmatic, open-label, controlled trialLancet Infectious DiseasesTilføjet 9. januar 2026
-
Beta-thalassemia and a missing malaria landscapeTrends in ParasitologyTilføjet 8. januar 2026
-
Wolbachia for malaria controlTrends in ParasitologyTilføjet 8. januar 2026
-
Development and evaluation of a diagnostic aiding tool for differentiating tropical fevers using artificial intelligence approach: a study protocol from tertiary care hospital in South IndiaBMJ OpenTilføjet 6. januar 2026
-
Housing modifications for heat adaptation, thermal comfort and malaria vector control in rural African settlementsNature MedicineTilføjet 5. januar 2026
-
Artemisinin‐Based Combination Therapies in East Africa: A Systematic Review of Quality, Clinical Efficacy, and Regulatory Progress Towards Sustainable Malaria ControlTropical Medicine & International HealthTilføjet 26. december 2025
-
Post-Infectious Guillain–Barré Syndrome During a Cholera Outbreak in Yemen: A Paediatric Case with Confirmed Campylobacter ExposureInternational Journal of Infectious DiseasesTilføjet 25. december 2025
-
[News] Suriname: first malaria-free country in the Amazon regionLancet MicrobeTilføjet 23. december 2025
-
[Articles] Direct and indirect protection against scabies through ivermectin mass drug administration designed for malaria in Mozambique: a substudy nested within a cluster-randomised, controlled trialLancet MicrobeTilføjet 23. december 2025
-
[Articles] Efficacy of ProC6C-AlOH/Matrix-M against Plasmodium falciparum infection and mosquito transmission: a phase 2, randomised, controlled human malaria infection studyLancet Infectious DiseasesTilføjet 17. december 2025